Meyer Andrew Hollman — SEC Form 4 filings
SEC reporting owner CIK 1864159. 11 Form 4 filings on record with FilingPulse; latest filed 2026-01-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-09-27 to 2026-01-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 10 filings — 101,879 shares, $4,221,183 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 50,000 shares @ $45.96 ($2,297,755) in Janux Therapeutics, Inc., filed 2024-09-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 11 | — | 19 legs · 101,879 sh · $4,221,183 | 24 |
Form 4 filings — Meyer Andrew Hollman
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-02 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 1,879 @ $13.73 | EDGAR |
| 2025-12-03 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,333 @ $10.59 · Sale (S): 2,700 @ $32.85 · Sale (S): 633 @ $33.52 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,333 @ $10.59 · Sale (S): 3,333 @ $30 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 9,999 @ $4.21 · Option exercise (M): 6,666 @ $10.59 · Sale (S): 16,665 @ $30.06 · Option exercise (M): 9,999 (derivative) @ $0 · Option exercise (M): 6,666 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,333 @ $4.21 · Sale (S): 2,933 @ $31.95 · Sale (S): 400 @ $32.60 · Option exercise (M): 3,333 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,334 @ $4.21 · Sale (S): 3,334 @ $30 · Option exercise (M): 3,334 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,334 @ $4.21 · Sale (S): 2,433 @ $31.88 · Sale (S): 901 @ $32.85 · Option exercise (M): 3,334 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 3,334 @ $4.21 · Sale (S): 2,418 @ $42.08 · Sale (S): 816 @ $42.77 · Sale (S): 100 @ $43.60 · Option exercise (M): 3,334 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Janux Therapeutics, Inc. (JANX) | Grant/award (A): 18,000 @ $0 · Sale (S): 2,922 @ $53.76 · Sale (S): 5,768 @ $54.51 · Sale (S): 3,444 @ $55.76 · Sale (S): 1,000 @ $56.78 · Sale (S): 200 @ $57.37 · +1 more | EDGAR |
| 2024-12-20 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 9,880 @ $20.24 · Option exercise (M): 1 @ $14.02 · Option exercise (M): 9,880 (derivative) @ $0 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 50,000 @ $4.21 · Sale (S): 50,000 @ $45.96 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1864159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →